cytarabine has been researched along with rhamnose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S; Duerr, B; Serif, G | 1 |
| Benatti, U; Bisso, A; De Flora, A; Sturla, L; Tonetti, M; Zanardi, D | 1 |
| Jin, L; Li, Y; Liu, X; Lu, L; Qu, J; Xiao, M; Xu, L; Yin, Z | 1 |
1 review(s) available for cytarabine and rhamnose
| Article | Year |
|---|---|
The metabolism of 6-deoxyhexoses in bacterial and animal cells.
Topics: Animals; Carbohydrate Epimerases; Fucose; Guanosine Diphosphate Fucose; Humans; Hydro-Lyases; Models, Chemical; Rhamnose | 1998 |
2 other study(ies) available for cytarabine and rhamnose
| Article | Year |
|---|---|
An epimerase-reductase in L-fucose synthesis.
Topics: Animals; Carbohydrate Epimerases; Escherichia coli Proteins; Fucose; Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose; Ketone Oxidoreductases; Kinetics; Molecular Weight; Multienzyme Complexes; Rhamnose; Sugar Alcohol Dehydrogenases; Swine; Thyroid Gland | 1988 |
Enzymatic rhamnosylation of anticancer drugs by an α-L-rhamnosidase from Alternaria sp. L1 for cancer-targeting and enzyme-activated prodrug therapy.
Topics: Alternaria; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytarabine; Floxuridine; Glycoside Hydrolases; Humans; Hydroxyurea; Molecular Targeted Therapy; Neoplasms; Prodrugs; Rhamnose | 2019 |